The Food and Drug Administration granted breakthrough therapy designation to a treatment regimen of two investigational drugs for patients with chronic hepatitis C virus who did not respond to ... Science Daily: A drug already in trials may finally stop hepatitis E Scientists have identified a potential new weapon against hepatitis E, a virus with no approved treatment and tens of thousands of deaths each year. The drug bemnifosbuvir, currently in trials for ...

Understanding the Context

Hepatitis C infection. Computer illustration showing liver and close-up view of hepatitis C viruses. Studies show that mortality, morbidity, and hepatic decompensation risks increase with coinfection ... Hepatitis C and opioid use disorder are both chronic but treatable conditions.

Key Insights

Yet many Americans living with this deadly combination aren’t offered treatment. Imagine going to your doctor with strep ... Figure 1. The direct-acting antiviral targets in the hepatitis C virus replication cycle. NS3/4A protease inhibitors target the NS3/4A protease enzyme which is needed for the virus to develop the ...

Final Thoughts

U ntil recently, most people diagnosed with hepatitis C were baby boomers, many of whom got the infection via a blood transfusion. As of 2024, hepatitis C is mostly spread via needles, syringes, and ... FierceBiotech: GSK hep B treatment’s efficacy slips 60% in full phase 2 readout, but phase 3 going ahead